Emgality 120 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F7WSM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,674
Award facts
- Contract value 100% obligated
- $1,674.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,674.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of December 11, 2025. This is a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA's Medical Supply Chain, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The delivery of Emgality, a migraine treatment medication, reflects AmerisourceBergen's role in supplying specialty pharmaceuticals to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible and comprehensive contract framework.
Quick answers
Who was awarded contract SPE2DR26F7WSM?
SPE2DR26F7WSM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F7WSM worth?
The government has obligated $1,674 on SPE2DR26F7WSM.
Is contract SPE2DR26F7WSM an order under another contract?
Yes. SPE2DR26F7WSM is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WSM competed?
The extent of competition for SPE2DR26F7WSM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award